Lithium borohydride → HCID 56932819, compound
Reaction equation
[CH3:1][N:2]1[CH:6]=[C:5]([NH:7][C:8]2[N:13]=[C:12]3[N:14]([CH2:17][C:18]4[CH:19]=[C:20]([N:24]5[CH2:29][CH2:28][O:27][CH2:26][C:25]5=[O:30])[CH:21]=[CH:22][CH:23]=4)[N:15]=[CH:16][C:11]3=[CH:10][N:9]=2)[CH:4]=[N:3]1.[BH4-].[Li+]>CO>[CH3:1][N:2]1[CH:6]=[C:5]([NH:7][C:8]2[N:13]=[C:12]3[N:14]([CH2:17][C:18]4[CH:19]=[C:20]([N:24]5[CH2:29][CH2:28][O:27][CH2:26][CH:25]5[OH:30])[CH:21]=[CH:22][CH:23]=4)[N:15]=[CH:16][C:11]3=[CH:10][N:9]=2)[CH:4]=[N:3]1Participants
Reactant 2
Product 1
Reagents, catalysts & solvents 1
Procedure
To a solution of 4-(3-((6-(1-methyl-1H-pyrazol-4-ylamino)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)methyl)phenyl)morpholin-3-one (45 mg, 0.12 mmol) in 4 mL methanol was added lithium borohydride (170 mg, 70 eq in seven portions every 10 min). The reaction mixture was evaporated and the residue partitioned between ethyl acetate and water. The aqueous phase was extracted with ethyl acetate, the combined organic phases dried over sodium sulfate and evaporated. The residue was purified with the preparative HPLC to yield the title compound (5 mg, 12 μmol, 10%). 1H NMR (d6-DMSO) δ 8.22 (s, 1H), 7.78 (s, 1H), 7.37-7.32 (m, 3H), 7.29-7.24 (m, 1H), 7.12-7.08 (m, 1H), 7.01 (s, 1H), 6.06 (s, 1H), 5.16 (s, 2H), 4.45 (s, 2H), 4.18 (s, 2H), 3.96-3.91 (m, 2H), 3.76 (s, 3H), 3.68-3.63 (m, 2H); LC-MS method B, (ES+) 407.2, RT=4.04 min.
Workup
- customThe reaction mixture was evaporated
- customthe residue partitioned between ethyl acetate and water
- extractionThe aqueous phase was extracted with ethyl acetate
- dry with materialthe combined organic phases dried over sodium sulfate
- customevaporated
- customThe residue was purified with the preparative HPLC
Sources & evidence
- ORD record
- ord-764afc230a104bafb35fddc1016087fc
- Source dataset
- uspto-grants-2015_05
- Patent number
- US09040545B2
Reaction notes
Loading…